Valuation: PolyPeptide Group AG

Market Cap 1.56B 1.8B 1.45B 1.34B 2.52B 172B 2.57B 17.17B 6.72B 85.27B 6.75B 6.61B 287B P/E 2026 *
57.1x
P/E 2027 * 31.3x
Enterprise Value 1.66B 1.92B 1.54B 1.42B 2.68B 183B 2.73B 18.29B 7.16B 90.81B 7.19B 7.03B 305B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 2.98x
Free-Float
39.12%
Yield 2026 *
-
Yield 2027 * 0.07%
1 day-0.28%
1 week+0.34%
Current month-6.70%
1 month-9.02%
3 months+12.28%
6 months+63.81%
Current year+68.20%
1 week 43.75
Extreme 43.75
44.05
1 month 41.55
Extreme 41.55
50.1
Current year 23.1
Extreme 23.1
50.1
1 year 20.1
Extreme 20.1
50.1
3 years 13.22
Extreme 13.22
50.1
5 years 13.22
Extreme 13.22
147.4
10 years 13.22
Extreme 13.22
147.4
Manager TitleAgeSince
Chief Executive Officer 54 2023-04-11
Director of Finance/CFO 54 2024-01-01
Chief Tech/Sci/R&D Officer 54 -
Director TitleAgeSince
Director/Board Member 73 2005-12-31
Chairman 69 2021-03-31
Director/Board Member 62 2020-12-31
Date Insider Type Main position Quantity % Market Cap.
11/13/23 Buy 2,500 0.0075%
10/12/23 Buy 159,959 0.4829%
4/6/23 Buy 45,842 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
-0.28%+0.34%+93.82%+114.15% 1.8B
-2.08%-4.59%+54.19%+151.04% 1,030B
-0.82%-3.16%+54.83%+52.25% 617B
-2.38%-2.75%+33.44%+68.62% 455B
-0.07%-0.51%+37.42%+30.56% 350B
-0.28%-0.06%+34.64%+39.26% 299B
-0.75%-0.13%+11.74%+13.12% 265B
-8.05%-4.57%-2.72%-43.98% 225B
-1.64%+1.94%+29.90%+63.71% 209B
-1.16%+0.24%+15.43%+70.24% 163B
Average -1.74%+4.37%+36.27%+55.90% 361.45B
Weighted average by Cap. -1.74%+4.87%+38.65%+71.92%

Financials

2026 *2027 *
Net sales 492M 566M 457M 421M 794M 54.06B 808M 5.41B 2.12B 26.85B 2.13B 2.08B 90.3B 568M 654M 527M 486M 916M 62.41B 933M 6.24B 2.44B 31B 2.46B 2.4B 104B
Net income 23.54M 27.1M 21.86M 20.16M 37.97M 2.59B 38.66M 259M 101M 1.28B 102M 99.54M 4.32B 43.85M 50.48M 40.72M 37.55M 70.74M 4.82B 72.02M 482M 189M 2.39B 190M 185M 8.05B
Net Debt 101M 117M 94.22M 86.89M 164M 11.15B 167M 1.12B 437M 5.54B 439M 429M 18.63B 130M 149M 120M 111M 209M 14.25B 213M 1.43B 558M 7.08B 561M 548M 23.81B
Logo PolyPeptide Group AG
Polypeptide Group AG is a Switzerland-based Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Employees
1,440
Date Price Change Volume
26-07-31 CHF 43.90 -0.11% 37,197
26-07-30 CHF 43.95 +0.23% 262,502
26-07-29 CHF 43.85 +0.23% 168,750
26-07-28 CHF 43.75 -0.11% 332,864
26-07-27 CHF 43.80 +0.11% 526,351
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
47.33EUR
Average target price
41.80EUR
Spread / Average Target
-11.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PPGN Stock